5 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Breast Cancer WEight Loss Study (BWEL Study)Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, Skin and Connective Tissue Diseases, adenocarcinoma, breast carcinoma in situ, breast disorder, breast neoplasm, carcinoma, ductal breast carcinoma in situ, epithelial neoplasm, in situ carcinoma, invasive breast carcinoma, neoplasm, skin disorder, synchronous bilateral breast carcinomaActive, not recruitingPhase 32026-09-02NCT02750826
A Study to Evaluate How the Study Drug Moves Through the Body, Adverse Events, and How the Body Tolerates ABBV-547 InjectionsHealthy VolunteerActive, not recruitingPhase 12026-07-24NCT07232004
MiSight 1 Day Safety Post-Approval Studyeye disorder, myopia, refractive errorActive, not recruitingNot applicable2026-07-08NCT05285527
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung CancerPreviously Treated Non-Small Cell Lung CancerRecruitingPhase 2 / Phase 32026-05-18NCT03851445
Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Moderate to Severe Plaque Psoriasis Treated With Subcutaneous (SC) Injection of Risankizumab Who Have Completed Participation in Study M19-977Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, psoriasis, skin disorderActive, not recruitingPhase 32025-08-12NCT04862286